News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
583,453 Results
Type
Article (39637)
Company Profile (312)
Press Release (543504)
Multimedia
Podcasts (68)
Webinars (11)
Section
Business (164462)
Career Advice (2395)
Deals (29637)
Drug Delivery (104)
Drug Development (77617)
Employer Resources (142)
FDA (14066)
Job Trends (12615)
News (290097)
Policy (27701)
Tag
Academia (2594)
Accelerated approval (6)
Adcomms (26)
Allergies (85)
Alliances (41896)
ALS (96)
Alzheimer's disease (1440)
Antibody-drug conjugate (ADC) (143)
Approvals (14055)
Artificial intelligence (259)
Autoimmune disease (27)
Automation (15)
Bankruptcy (320)
Best Places to Work (10405)
BIOSECURE Act (16)
Biosimilars (95)
Biotechnology (255)
Bladder cancer (84)
Brain cancer (29)
Breast cancer (285)
Cancer (2280)
Cardiovascular disease (191)
Career advice (2015)
Career pathing (32)
CAR-T (156)
Cell therapy (440)
Cervical cancer (18)
Clinical research (63030)
Collaboration (828)
Company closure (1)
Compensation (389)
Complete response letters (24)
COVID-19 (2519)
CRISPR (46)
C-suite (262)
Cystic fibrosis (99)
Data (2224)
Decentralized trials (2)
Denatured (15)
Depression (53)
Diabetes (266)
Diagnostics (5667)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (40)
Drug discovery (123)
Drug pricing (102)
Drug shortages (22)
Duchenne muscular dystrophy (100)
Earnings (61004)
Editorial (40)
Employer branding (19)
Employer resources (130)
Events (88162)
Executive appointments (750)
FDA (15295)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (736)
Gene editing (114)
Generative AI (20)
Gene therapy (336)
GLP-1 (732)
Government (4171)
Grass and pollen (5)
Guidances (78)
Healthcare (16846)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (136)
Indications (30)
Infectious disease (2660)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (48)
Intellectual property (94)
Interviews (518)
IPO (13975)
IRA (45)
Job creations (2639)
Job search strategy (1648)
Kidney cancer (11)
Labor market (21)
Layoffs (454)
Leadership (23)
Legal (5766)
Liver cancer (76)
Lung cancer (332)
Lymphoma (147)
Machine learning (7)
Management (52)
Manufacturing (288)
MASH (74)
Medical device (10816)
Medtech (10820)
Mergers & acquisitions (16176)
Metabolic disorders (698)
Multiple sclerosis (80)
NASH (22)
Neurodegenerative disease (106)
Neuropsychiatric disorders (34)
Neuroscience (2014)
NextGen: Class of 2025 (5727)
Non-profit (3964)
Now hiring (35)
Obesity (364)
Opinion (234)
Ovarian cancer (76)
Pain (92)
Pancreatic cancer (83)
Parkinson's disease (156)
Partnered (20)
Patents (231)
Patient recruitment (110)
Peanut (47)
People (53331)
Pharmaceutical (55)
Pharmacy benefit managers (12)
Phase I (19864)
Phase II (27917)
Phase III (20689)
Pipeline (1220)
Policy (143)
Postmarket research (2289)
Preclinical (8343)
Press Release (59)
Prostate cancer (108)
Psychedelics (37)
Radiopharmaceuticals (255)
Rare diseases (403)
Real estate (4304)
Recruiting (55)
Regulatory (19862)
Reports (25)
Research institute (2194)
Resumes & cover letters (346)
Rett syndrome (5)
RNA editing (5)
RSV (40)
Schizophrenia (77)
Series A (129)
Series B (86)
Service/supplier (2)
Sickle cell disease (54)
Special edition (13)
Spinal muscular atrophy (151)
Sponsored (28)
Startups (3080)
State (2)
Stomach cancer (14)
Supply chain (60)
Tariffs (36)
The Weekly (52)
Vaccines (653)
Venture capitalists (39)
Weight loss (247)
Women's health (26)
Worklife (17)
Date
Today (110)
Last 7 days (735)
Last 30 days (2520)
Last 365 days (30809)
2025 (10354)
2024 (33065)
2023 (36979)
2022 (47771)
2021 (51255)
2020 (49043)
2019 (41378)
2018 (31213)
2017 (28932)
2016 (27373)
2015 (32041)
2014 (24526)
2013 (19718)
2012 (20882)
2011 (21843)
2010 (19719)
Location
Africa (713)
Alabama (54)
Alaska (4)
Arizona (168)
Arkansas (12)
Asia (35506)
Australia (7099)
California (5682)
Canada (1937)
China (507)
Colorado (245)
Connecticut (240)
Delaware (149)
Europe (79517)
Florida (838)
Georgia (182)
Idaho (51)
Illinois (479)
India (23)
Indiana (261)
Iowa (8)
Japan (159)
Kansas (92)
Kentucky (21)
Louisiana (10)
Maine (52)
Maryland (842)
Massachusetts (4243)
Michigan (200)
Minnesota (344)
Mississippi (2)
Missouri (79)
Montana (24)
Nebraska (22)
Nevada (57)
New Hampshire (64)
New Jersey (1636)
New Mexico (25)
New York (1598)
North Carolina (927)
North Dakota (6)
Northern California (2454)
Ohio (175)
Oklahoma (10)
Oregon (32)
Pennsylvania (1217)
Puerto Rico (12)
Rhode Island (30)
South America (974)
South Carolina (19)
South Dakota (1)
Southern California (2189)
Tennessee (88)
Texas (822)
United States (21261)
Utah (171)
Virginia (136)
Washington D.C. (57)
Washington State (518)
West Virginia (3)
Wisconsin (47)
583,453 Results for "apim therapeutics as".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Nordic Nanovector comment on Proposed Merger with APIM Therapeutics
Nordic Nanovector ASA desires to share more information with the Company’s shareholders about the proposed merger between the Company and APIM Therapeutics.
November 21, 2022
·
6 min read
Nordic Nanovector update following shareholder vote against proposed merger with APIM Therapeutics
Nordic Nanovector ASA (OSE: NANOV) (“Nordic Nanovector” or the “Company”) today announces an update following the Extraordinary General Meeting held on 1 December at which the proposed merger transaction with APIM Therapeutics AS (“APIM”) did not obtain a sufficient majority of votes and was therefore voted down.
December 9, 2022
·
2 min read
Deals
Nordic Nanovector Launches Dedicated Area on its Website in Norwegian for Information on the Proposed Merger with APIM Therapeutics
Nordic Nanovector ASA has today launched a new dedicated area on its website ( www.nordicnanovector.com ) with information in Norwegian for shareholders relating to its proposed merger with APIM Therapeutics (“APIM”).
November 25, 2022
·
6 min read
Deals
Nordic Nanovector: Invitation to webcast regarding proposed merger with APIM Therapeutics
Nordic Nanovector ASA will host a webcast, including a question and answers session on Thursday, November 24 at 4.30 P.M. CET.
November 23, 2022
·
3 min read
Press Releases
Ascidian Therapeutics Announces Formation of Scientific Advisory Board
May 6, 2025
·
5 min read
Press Releases
Astria Therapeutics to Present at Upcoming Citizens Life Sciences Conference
April 30, 2025
·
1 min read
Press Releases
Verismo Therapeutics Announces Poster Presentation at ASCO 2025
April 24, 2025
·
3 min read
Press Releases
Axovia Therapeutics Announces Three Upcoming Poster Presentations at ASGCT
April 28, 2025
·
3 min read
Press Releases
Adcentrx Therapeutics to Present First Clinical Data for ADRX-0706 Nectin-4 ADC at ASCO 2025
April 23, 2025
·
4 min read
Press Releases
Scribe Therapeutics to Highlight In Vivo CRISPR-based Genome Editing Data for Duchenne Muscular Dystrophy at ASGCT 2025, in Addition to Joint Presentation with Prevail Therapeutics, a Part of Lilly’s Gene Therapy Division
May 5, 2025
·
3 min read
1 of 58,346
Next
